Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells. (Q53950070)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12439752%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

title

Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12439752%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12439752%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Kelly K Hunt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12439752%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Tongyu Lin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12439752%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Xuefeng Huang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12439752%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Lidong Zhang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12439752%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Jack A Roth

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12439752%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Momiao Xiong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12439752%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Steven A Curley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12439752%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Yinhua Yu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12439752%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Bingliang Fang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12439752%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

language of work or name

English

0 references

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12439752%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12439752%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12439752%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12439752%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

8020-8028

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12439752%20AND%20SRC:MED&resulttype=core&format=json

Death receptor ligands, in particular TRAIL, to overcome drug resistance

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205926

7 January 2021

Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205926

7 January 2021

A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205926

7 January 2021

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205926

7 January 2021

Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205926

7 January 2021

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Cli

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205926

7 January 2021

The potential of TRAIL for cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205926

7 January 2021

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205926

7 January 2021

A survey of telomerase activity in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205926

7 January 2021

Growth, differentiation, and transformation of human mammary epithelial cells in culture.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205926

7 January 2021

Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205926

7 January 2021